VIDEO: Should women wait to get mammograms after COVID vaccination?

Stacey Wolfson, MD, chief resident, and Beatriu Reig, MD, MPH, clinical assistant professor of radiology, Department of Radiology, NYU Grossman School of Medicine, explain the findings of a study of axillary adenopathy in mammography patients who recently had a COVID-19 vaccine. They were the lead authors of the study published in Radiology. Their study looked at 1,200 women who were vaccinated against SARS-CoV-2 and received breast imaging exams, and they found several cancers, so their conclusion is not to wait for breast imaging after receiving a COVID vaccine or booster.

In early 2021, it was found that the COVID vaccines can cause swollen lymph nodes (adenopathy) that mimics cancer on mammograms. For this reason, women were told to hold off several weeks before getting breast imaging after being vaccinated. However, follow up radiology studies found the axillary adenopathy can last for 10 weeks or more after a COVID vaccination. 

This new study suggests women should undergo screening regardless of when they are vaccinated, because cancers can otherwise go un-detected. There is fear at many women's imaging centers that women who missed their annual exams due to COVID, combined with women hold off on exams because of vaccinations, may allow cancers to grow infected and lead to a higher volume of more serious cancer cases.

Read more in the article Women do not need to delay their mammogram appointment after COVID-19 vaccination.


Related COVID and Mammography Content:

Molecular imaging group shares updates for managing COVID-19 vaccine effects on PET/CT exams

How radiology providers can minimize mammography recalls among COVID-vaccinated patients

Radiologists report COVID vaccine side effects mimicking breast cancer on mammograms

These ultrasound features distinguish between COVID vaccine-related and malignant adenopathy

Cardiac MRI sheds new light on vaccine-related myocarditis

Most routine imaging should be scheduled 6 weeks after 2nd vaccine dose, major cancer centers say

Managing COVID-19 vaccine side effects: Harvard radiologists share their ‘pragmatic’ approach

Enterprise imaging firm releasing tool to help radiologists manage vaccine side effects on mammograms

COVID-19 vaccine update: Radiologists report side effects mimicking breast cancer on mammograms

Women do not need to delay their mammogram appointment after COVID-19 vaccination.

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.